Lung cancer screening: New guidelines, new challenges

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Smoking is still the number one preventable cause of death in the U.S.​ and lung cancer is far and away the number one cause of cancer death in the U.S. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
David Balis, MD
Professor, general internal medicine, Department of Internal Medicine, UT Southwestern Medical Center; Director, Smoking Cessation Clinics, Parkland and UT Southwestern
Table of Contents

YOU MAY BE INTERESTED IN

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report. Incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% higher in 2002. In 2021, for the first time, lung cancer incidence was higher in women under 65 than in men. 
Lauren Averett Byers, professor of thoracic/head & neck medical oncology at the University of Texas MD Anderson Cancer Center, received the 2025 Edith and Peter O’Donnell Award in Medicine from the Texas Academy of Medicine, Engineering, Science and Technology. The award recognizes her fundamental discoveries and contributions to identifying novel therapeutic strategies for small cell lung cancer, which have paved the way for personalized treatments, even in the most highly recalcitrant cancers.
David Balis, MD
Professor, general internal medicine, Department of Internal Medicine, UT Southwestern Medical Center; Director, Smoking Cessation Clinics, Parkland and UT Southwestern

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login